Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 4Terminated 2

Sponsor Class

NETWORK 3OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Leukemia 20Breast Neoplasms 9Lymphoma 7Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precancerous Conditions 4Lymphoma, Follicular 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Gliosarcoma 3Glioblastoma 3Esophageal Neoplasms 3Congenital Abnormalities 3Central Nervous System Neoplasms 3Adenocarcinoma Of Esophagus 3Wilms Tumor 2Stomach Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2

Interventions

Rituximab 168Cyclophosphamide 142Peripheral Blood Stem Cell Transplantation 84fludarabine phosphate 68Filgrastim 64Etoposide 63Radiotherapy 55Vincristine 47Prednisone 45Mycophenolic Acid 44Melphalan 40Whole-Body Irradiation 39Cyclosporine 39Busulfan 39Tacrolimus 36Doxorubicin 34Cytarabine 33Lenalidomide 29Carmustine 28Antilymphocyte Serum 28Methotrexate 27Methylprednisolone 26Bortezomib 26Bendamustine Hydrochloride 26sargramostim 21ibritumomab tiuxetan 20obinutuzumab 19ibrutinib 18fludarabine 18Dexamethasone 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Lymphoma, Follicular × Microarray Analysis × Clear all
NCT01075321 2020-10-22

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Mayo Clinic

Phase 1/2 Completed
58 enrolled 12 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT00898963 2020-07-31

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

Eastern Cooperative Oncology Group

Completed
175 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT01150643 2017-05-17

Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab

Eastern Cooperative Oncology Group

Completed
559 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00896922 2017-02-28

S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

SWOG Cancer Research Network

Completed
180 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡